JPRN-jRCT1051190043
Recruiting
Phase 2
Safety and efficacy of Budesonide administration after endoscopic balloon dilation for Crohn's disease patients with intestinal stenosis - OGF1707
Takehara Tetsuo0 sites15 target enrollmentSeptember 2, 2019
ConditionsCrohn's disease
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Crohn's disease
- Sponsor
- Takehara Tetsuo
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Mild to moderate active Crohn's disease patients with written consent at Osaka University Hospital and affiliated hospitals, who have intestinal stenosis and are scheduled or recieved endoscopic balloon dilation (EBD), are included.
Exclusion Criteria
- •Patients with more than 5 centimeters long stenosis
- •Patients with internal or external fistula
- •Patients with active infection, including abscess
- •Patients with oral treatment of antithrombotic drugs or low platelet that counts less than 50000 per microlitter
- •Patients with cancer
- •Patients under 20 years old
- •Patients with severy bad general condition
- •Patients who are administered steroids within 4 weeks
- •Patients who are judged inapropriate by doctors
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Safety and efficacy of Budesonide administration after endoscopic ballon dilation for Crohn disease patients with intestinal stenosisCrohn's diseaseJPRN-UMIN000031839Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology17
Unknown
Phase 3
Investigation of Safety and Efficacy of Budesonide Inhalation Suspension in the Long-Term Use in Japanese Children With Bronchial Asthma (Open Long-Term Extension Study Following Study SD-004-0765AsthmaJPRN-jRCT2080220398AstraZeneca
Recruiting
Phase 3
Effectiveness of the Treatment With Budesonide Nebuliser among Patients with Acute AsthmaIRCT20170531034256N2Shahid Beheshti University of Medical Sciences70
Recruiting
Not Applicable
eurosis.Randomised controlled trialPreterm infantsInhaled corticosteroidsBronchopulmonary dysplasiaGerandomiseerd gecontroleerd onderzoekPrematuur geboren kinderenInhalatiecorticosteroïdenBronchopulmonale dysplasieNL-OMON29190eurosis Study Center, Prof. Dr. med. Christian-F. Poets en PD. Dr. med Dirk Bassler, MSc Medical University - Tuebingen GermanyNeurosis study Center, neurosis.studycoordinator@med.uni-tuebingen.de20
Active, not recruiting
Phase 1
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - NEUROSISHigh risk of bronchopulmonary dysplasia in very preterm neonatesMedDRA version: 12.1Level: LLTClassification code 10006475Term: Bronchopulmonary dysplasiaEUCTR2009-012203-26-EEniversitätsklinikum Tübingen863